COVID-19 epidemiology in rheumatic diseases in Tuscany: A case-control study - 29/04/21
Highlights |
• | The different screening methodology to capture cases of SARS-CoV-2 infections in patients with rheumatic diseases may result in a variation in the incidence of COVID-19 compared to the general population. |
• | Study confirms the role of corticosteroids in increasing the risk of SARS-CoV-2 infection in patients with chronic rheumatic diseases (RA, AS, PsA) rather than in while connective tissue diseases. |
• | Patients with chronic rheumatic diseases require careful surveillance through serological tests and confirmations with RT-PCR. |
Keywords : COVID-19, Rheumatic disease, B-DMARDs
Esquema
Vol 88 - N° 3
Artículo 105131- mai 2021 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.